INTRAVENOUS IMMUNOGLOBULIN (IVIG)

Course overview

INTRAVENOUS IMMUNOGLOBULIN (IVIG) IS A POOLED ANTIBODY AND A BIOLOGICAL AGENT USED IN THE MANAGEMENT OF VARIOUS IMMUNODEFICIENCY STATES AND A PLETHORA OF OTHER CONDITIONS INCLUDING AUTOIMMUNE, INFECTIOUS, AND INFLAMMATORY STATES. THE ULTIMATE GOAL OF THIS THERAPY IS TO NORMALIZE A COMPROMISED IMMUNE SYSTEM. THIS ACTIVITY REVIEWS THE INDICATIONS, MECHANISM OF ACTION, CONTRAINDICATIONS, ADVERSE EFFECTS, AND MONITORING OF IVIG IN THE TREATMENT OF SEVERAL IMMUNE DEREGULATED STATES. IT ALSO HIGHLIGHTS THE KEY INFORMATION PERTINENT TO THE HEALTHCARE TEAMS MANAGING PATIENTS WITH CONDITIONS AFFECTING THE IMMUNE SYSTEM AND OTHER IMMUNE-RELATED CONDITIONS.